A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman, A. L. & Tainsky, M. A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene27, 5975–5987 (2008). source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher, L. A. et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol. Med.2, 458–471 (2010). sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl, L. et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod. Pathol.24, 1015–1022 (2011). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke, M. et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell18, 135–146 (2010). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell21, 105–120 (2012). sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso, M. et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv.454, 291–302 (2009). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,301–1,400 of 2,272
Senotherapy for chronic lung disease
Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 18
Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer
Melia, F., Udomjarumanee, P., Zinovkin, D. A., Arghiani, N., & Pranjol, M. Z. I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.975644 · Cited by 16
“As a result, chronic SASP generates low-grade inflammation, excessive cell proliferation and angiogenesis, causing tissue damage and potentially contributing to the promotion of a pro-tumorigenic environment (8, 23, 28, 29).”
BackgroundAn Agent-Based Model of Radiation-Induced Lung Fibrosis
Cogno, N., Bauer, R., & Durante, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213920 · Cited by 17
Effects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 16
Typhoid toxin hijacks Wnt5a to establish host senescence and Salmonella infection
ElGhazaly, M., Collins, M. O., Ibler, A. E., & Humphreys, D. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113181 · Cited by 13
Çobanoglu, Ö., Delval, L., Ferrari, D. P., Deruyter, L., Heumel, S., Wolowczuk, I., Hussein, A., Menevse, A. N., Bernard, D., Beckhove, P., et al. (2023) · Aging Cell · doi:10.1111/acel.14007 · Cited by 12
Han, X., Lu, L., Xie, J., Lei, Q., Li, Y., Liu, H., Sun, H., Zhang, X., & Gou, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176865 · Cited by 15
Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma
Ruan, H., Wang, T., Yang, C. G., Jin, G., Gu, D., Deng, X., Wang, C., Qin, W., & Jin, H. (2016) · Scientific Reports · doi:10.1038/srep32421 · Cited by 15
Self-citationp53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer
Garnett, S., Dutchak, K., McDonough, R. V., & Dankort, D. L. (2017) · Oncogene · doi:10.1038/onc.2017.235 · Cited by 18
Saccà, S. C., Vernazza, S., Iorio, E. L., Tirendi, S., Bassi, A. M., Gandolfi, S., & Izzotti, A. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.06.003 · Cited by 17
Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts
Cobb, M., Tao, S., Shortt, K., Girgis, M., Hauptman, J., Schriewer, J. M., Chin, Z., Dorfman, E., Campbell, K., Heruth, D. P., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2022 · Cited by 15
“TGF-b, cytokine, and p38 mitogen-activated protein kinase pathways have been previously shown to contribute to development of the senescent phenotype (91, 92).”
BackgroundSinha, V. C., Qin, L. F., & Li, Y. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0481-t · Cited by 18
Circulating microRNAs in aging
Bonafè, M., & Olivieri, F. (2015) · Oncotarget · doi:10.18632/oncotarget.3175 · Cited by 14
Long, X., Li, Y., Yang, M., Huang, L., Gong, W., & Kuang, E. (2016) · Journal of Virology · doi:10.1128/jvi.00999-16 · Cited by 14
Raats, D., Frenkel, N. C., van Schelven, S. J., Rinkes, I. H. M. B., Laoukili, J., & Kranenburg, O. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.87 · Cited by 17
Gao, L., OConnell, M., Allen, M., Liesveld, J. L., McDavid, A., Anolik, J. H., & Looney, R. J. (2019) · Cytokine · doi:10.1016/j.cyto.2019.05.012 · Cited by 15
Regulation of cellular senescence by retinoid X receptors and their partners
Martin, N., Ma, X., & Bernard, D. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111131 · Cited by 14
Clinical Implications of Cellular Senescence on Wound Healing
Resnik, S. G., Egger, A. N., Abujamra, B. A., & Jozic, I. (2020) · Current Dermatology Reports · doi:10.1007/s13671-020-00320-3 · Cited by 18
Zhang, K., Chen, C., Liu, Y., Chen, H., & Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12328 · Cited by 16
MAPKs in the early steps of senescence implemEMTation
Anerillas, C., Altés, G., & Gorospe, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1083401 · Cited by 13
“, 2021), and senescent cells express many of the receptors to which these extracellular ligands bind (Acosta et al., 2013; Rapisarda et al., 2017; Anerillas et al., 2022a; Anerillas et al., 2022b).”
BackgroundInfluentialWlaschek, M., Maity, P., Koroma, A. K., Geiger, H., Singh, K., & Scharffetter‐Kochanek, K. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.024 · Cited by 17
Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related Diseases
Liu, J., Yu, H., & Xu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071727 · Cited by 15
“This paracrine effect involves factors such as TGF-β family members, vascular endothelial growth factor (VEGF), and chemokines, among others [31,35,42], or trigger tissue repair.”
Tsang, V. S. K., Malaspina, A., & Henson, S. M. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00460-y · Cited by 15
“Additional drivers of this inflammatory metabolic state include inflammasome activation and IL-1 signalling, triggered by age-related accumulation of DAMPs and high glucose levels [70].”
Li, S., Hou, Y., Liu, K., Zhu, H., Qiao, M., Sun, X., & Li, G. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab298 · Cited by 13
Liu, H.-Y., Chang, C., Lu, C., Wu, S., Huang, B., Cheng, T., Lin, S., Ho, C.-J., Lee, M., Yang, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071477 · Cited by 18
“Furthermore, apart from the senescent cell itself, SASP can also induce paracrine senescence in neighboring healthy chondrocytes [86].”
BackgroundBarnes, P. J. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.001 · Cited by 15
Westin, E. R., Khodadadi‐Jamayran, A., Pham, L. K., Tung, M. L., & Goldman, F. D. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad207 · Cited by 15
“Furthermore, the SASP pathway can promote senescence to neighboring cells via paracrine/autocrine effects by releasing proinflammatory cytokines, chemokines, and growth factors within a niche (Acosta et al .”
BackgroundAndrogen signaling stabilizes genomes to counteract senescence by promoting XRCC4 transcription
Chen, Y., Zhen, Z., Chen, L., Wang, H., Wang, X., Sun, X., Song, Z., Wang, H., Lin, Y., Zhang, W., et al. (2023) · EMBO Reports · doi:10.15252/embr.202356984 · Cited by 16
“C motif chemokine ligand 2 (CCL2) plays a role in paracrine senescence (Acosta et al , 2013) and recruits immunosuppressive cells to inhibit the clearance of tumor cells (Eggert et al , 2016), while matrix metalloproteinases 1 and 3 (MMP1 and MMP3) remodel the extracellular matrix to facilitate…”
BackgroundXiong, J., Fu, Y., Huang, J., Wang, Y., Jin, X., Wan, X., Huang, L., & Huang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265525 · Cited by 14
Rossi, C., Venturin, M., Gubała, J., Frasca, A., Corsini, A., Battaglia, C., & Bellosta, S. (2023) · Biomedicines · doi:10.3390/biomedicines11123228 · Cited by 16
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Regulation of cellular senescence by innate immunity
Hou, J., Zheng, Y., & Gao, C. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230032 · Cited by 18
“Senescent cells can secrete SASP factors through autocrine and paracrine (Acosta et al. 2013; Coppe et al. 2010; Kuilman and Peeper 2009), which can activate immune responses, leading to the clearance of senescent cells (Krizhanovsky et al. 2008; Munoz-Espin and Serrano 2014).”
BackgroundSarad, K., Jankowska, U., Skupień-Rabian, B., Babler, A., Kramann, R., Dulak, J., & Jaźwa, A. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05028-7 · Cited by 16
Regulation of cell function and identity by cellular senescence
Huna, A., Massemin, A., Makulyte, G., Flaman, J., Martin, N., & Bernard, D. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202401112 · Cited by 14
Li, Y., Zhang, C., Cheng, H., Lv, L., Zhu, X., Ma, M., Xu, Z., He, J., Xie, Y., Yang, X., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112522 · Cited by 14
“SASP activation is a dynamic process that accompanies senescence establishment (Acosta et al., 2013b).”
BackgroundMethodRoles of Microenvironment on Mesenchymal Stem Cells Therapy for Osteoarthritis
Zhang, H., Jin, C., Hua, J., Chen, Z., Gao, W., Xu, W., Zhou, L., & Shan, L. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s475617 · Cited by 14
“57,58 The transcriptional activation of a SASP program affects the microenvironment in which senescent cells reside and reinforces cellular senescence.”
BackgroundCentromere inactivation during aging can be rescued in human cells
Sikder, S., Baek, S., Mcneil, T. R., & Dalal, Y. (2025) · Molecular Cell · doi:10.1016/j.molcel.2024.12.018 · Cited by 17
Senescent cell removal via JAG1‐NOTCH1 signalling in the epidermis
Yoshioka, H., Yamada, T., Hasegawa, S., Miyachi, K., Ishii, Y., Hasebe, Y., Inoue, Y., Tanaka, H., Iwata, Y., Arima, M., et al. (2021) · Experimental Dermatology · doi:10.1111/exd.14361 · Cited by 15
Iannuzzi, A. M., Giacomelli, C., Leo, M. D., Russo, L., Camangi, F., Tommasi, N. D., Braca, A., Martini, C., & Trincavelli, M. L. (2021) · Planta Medica · doi:10.1055/a-1471-6666 · Cited by 13
“While the transient presence of senescent cells can have beneficial functions in wound healing [18], the chronic persistence of stressors such as reactive oxygen species (ROS) promotes the increase of senescence that negatively affects the surrounding tissue leading to the senescence-associated secretory phenotype (SA…”
BackgroundStrzeszewska, A., Staniak, K., Czarnecka‐Herok, J., Rafiee, M., Herok, M., Mosieniak, G., Krijgsveld, J., & Sikora, E. (2021) · Cancers · doi:10.3390/cancers13092115 · Cited by 18
“SASP contributes also to chronic inflammation, leading to alterations in the tissue micro-environment and to tissue impairment [9,10], thus rendering a risk for the organism.”
BackgroundYang, Y., Ding, J., Chen, Y., Ma, G., Wei, X., Zhou, R., & Hu, W. M. (2022) · Human Cell · doi:10.1007/s13577-022-00676-7 · Cited by 13
“The chronic accumulation of senescent cells is increasingly recognized as a driver of various senescence features and plays an essential role in age-related diseases and tissue degeneration, such as OA [5, 6].”
BackgroundApplications of nanodiamonds in the diagnosis and treatment of neurological diseases
Tang, G. F., Zhang, M. R., Liu, Q., Tian, X., & R., R. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05434-2 · Cited by 13
Simultaneous augmentation of muscle and bone by locomomimetism through calcium-PGC-1α signaling
Ono, T., Denda, R., Tsukahara, Y., Nakamura, T., Okamoto, K., Takayanagi, H., & Nakashima, T. (2022) · Bone Research · doi:10.1038/s41413-022-00225-w · Cited by 16
“5% dimethyl sulfoxide (DMSO), 5% Tween 80 and 25% PEG 400 in phosphate–buffered saline (PBS).(48) For subcutaneous injection, LAMZ was dissolved into propylene glycol at a concentration of 1.”
MethodBajalović, N., Or, Y. Z., Woo, A. R. E., Lee, S. H., & Lin, V. C. L. (2022) · Biomedicines · doi:10.3390/biomedicines10081860 · Cited by 14
“Increased levels of proinflammatory cytokines and chemokines could enhance the immune surveillance of senescent cells and elicit paracrine senescence to suppress the adjacent tumor cells [57,58].”
BackgroundKehagias, P., Kindt, N., Krayem, M., Najem, A., Agostini, G., Reina, E. A., Bregni, G., Sclafani, F., Journé, F., Awada, A. H., et al. (2022) · Cells · doi:10.3390/cells11223663 · Cited by 15
“Our findings support that tumour cellular senescence response after regorafenib exposure is associated with mediators known to play a role in senescence-like phenotype switching [44].”
BackgroundPathogenesis of Osteoarthritis
Kapoor, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19560-5_1 · Cited by 20
Chen, X., Xu, Y., Cao, X., Chen, Y., Jiang, J., & Wang, K. (2015) · Medicine · doi:10.1097/md.0000000000001982 · Cited by 13
“As a member of IL-1 gene family, IL-1RN has been proven to act as an anti-inflammatory treatment in several chronic inflammatory diseases, which involve GC.(18,19) A significant association was found between progression and several SNPs which include rs9005 and their haplotypes in the gene for IL1RN, indicating that v…”
BackgroundHemati, K., Pourhanifeh, M. H., Fatemi, I., Hosseinzadeh, A., & Mehrzadi, S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220114151654 · Cited by 13
Detecting Senescence: Methods and Approaches
Crowe, E. P., Nacarelli, T., Bitto, A., Lerner, C. A., Sell, C., & Torres, C. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_23 · Cited by 14
Anwar, T., Sen, B., Aggarwal, S., Nath, R., Pathak, N., Katoch, A., Aiyaz, M., Trehanpati, N., Khosla, S., & Ramakrishna, G. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26227 · Cited by 14
“It was shown earlier that the inflammasomes play an important role in the inflammatory phenotype of the senescent cells (Acosta et al., 2013).”
BackgroundMalojirao, V. H., Vasquez, V., Kodavati, M., Mitra, J., Provasek, V., Voh, A. T. T., Liopo, A. V., Derry, P. J., Mikheev, A. M., Rostomily, R. C., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07983-3 · Cited by 13
“The progression to long-lasting senescencecancreateapro-in fl ammatoryenvironmentthatnotonlycauses damage to neighboring cells through paracrine senescence, but also drives chronic low-grade in fl ammation within the brain 41 – 43 .”
Stromal senescence contributes to age-related increases in cancer
Ye, J., Melam, A., & Stewart, S. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00840-9 · Cited by 17
“…transforming growth factor-β (TGFβ) family proteins, vascular endothelial growth factor (VEGF) and CC chemokine ligands (CCLs), can also induce secondary cellular senescence in adjacent tumour and stromal cells to further augment the protumorigenic effect of senescent stroma 88,114,279,280 .”
Li, S., Fang, X., Hu, S., Cai, K., Xu, H., Shi, Y., Ye, Z., Wang, X., Jiang, C., & Shao, Z. (2025) · ACS Nano · doi:10.1021/acsnano.5c11287 · Cited by 17
Zayed, M., & Iohara, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186931 · Cited by 16
“Interleukin-6, an inflamm-aging marker, is a specific SASP component that boosts senescence [54].”
BackgroundModelling the dynamics of senescence spread
Martin, L., Schumacher, L. J., & Chandra, T. (2023) · Aging Cell · doi:10.1111/acel.13892 · Cited by 11
“…of paracrine senescence spread can be determined through inference To estimate the parameters of the model, we propose a similar experiment to those described in Acosta et al. (Acosta et al., 2013), seeding a circle of primary senescent cells and watching the phenotype spread (section 4.3).”
BackgroundMethodResultInfluentialFlip a coin: cell senescence at the maternal–fetal interface
Gong, G.-S., Muyayalo, K. P., Zhang, Y., Lin, X., & Liao, A. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad071 · Cited by 14
“The identified paracrine signaling molecules are SASP factors, which indicates that high SASP activity results in cell senescence [28].”
BackgroundXie, W., Deng, L., Qian, R., Huang, X., Liu, W., & Tang, S. (2024) · Antioxidants · doi:10.3390/antiox13040420 · Cited by 13
Cellular senescence is a double‐edged sword in regulating aged immune responses to influenza
Torrance, B. L., Panier, H. A., Cadar, A. N., Martin, D., Lorenzo, E. C., Jellison, E. R., Bartley, J. M., & Haynes, L. (2024) · Aging Cell · doi:10.1111/acel.14162 · Cited by 11
“SASP also has the ability to induce senescence in nearby cells highlighting their pervasive nature leading to serious detrimental health outcomes (Acosta et al., 2013 ).”
BackgroundPrimary oocytes with cellular senescence features are involved in ovarian aging in mice
Yan, H., Miranda, E. A. D., Jin, S., Wilson, F., An, K., Godbee, B., Zheng, X., Brau-Rodríguez, A. R., & Lei, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-64441-6 · Cited by 20
Sugimoto, Y., Okamoto, K., Saito, H., Yamaguchi, T., Kinoshita, J., Nakamura, K., Takino, T., Endo, Y., Ninomiya, I., Ohta, T., et al. (2024) · Oncology Reports · doi:10.3892/or.2024.8788 · Cited by 13
“Furthermore, SASP factors induced by IL‑1a expression exhibit paracrine effects on the surrounding cells and induce cellular senescence (38,39).”
BackgroundFernández, L., Kong, C., Alkhoury, M., Tryfonos, M., Brighton, P. J., Rawlings, T. M., Muter, J., Gori, M. S., Leirós, C. P., Lucas, E. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76241-z · Cited by 16
Autophagy in the Cellular Consequences of Tobacco Smoking: Insights into Senescence
Akhtari, M., Jalalvand, M., Sadr, M., & Sharifi, H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70065 · Cited by 13
“These metabolites affect surrounding cells by inducing senescence [64].”
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Jacob, J., Aggarwal, A., Bhattacharyya, S., Sahni, D., Sharma, V., & Aggarwal, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177573 · Cited by 16
Aging and Lifestyle Modifications for Preventing Aging‐Related Diseases
Li, Q., Zhang, H., Xiao, N., Liang, G., Lin, Y., Yang, X. Y., Yang, J., Qian, Z., Fu, Y., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402797rr · Cited by 20
Wu, J., Liu, X., Liu, Y., Su, W., & Zhuo, Y. (2025) · Bioengineering · doi:10.3390/bioengineering12060563 · Cited by 14
Mahmoud, A. M., Biello, F., Maggiora, P. M., Bruna, R., Burrafato, G., Cappelli, M., Varughese, F. M., Martini, V., Platini, F., Deambrogi, C., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02237-3 · Cited by 14
Tackling cellular senescence by targeting miRNAs
Wang, Z., Gao, J., & Xu, C. (2022) · Biogerontology · doi:10.1007/s10522-022-09972-z · Cited by 15
Papadopoulou, A., Kalodimou, V. E., Mavrogonatou, E., Καραμάνου, Κ., YIACOUMETTIS, A. M., Panagiotou, P. N., Pratsinis, H., & Kletsas, D. (2022) · IUBMB Life · doi:10.1002/iub.2659 · Cited by 12
“, lipofuscin), the inability to proliferate and an exceptional secretome, the senescence-associated secretory phenotype (SASP), consisting of inflammatory cytokines, ECMdegrading enzymes, and ECM constituents.(1,2,22) SASP is the main phenotypic trait of senescent cells that has been connected with observed tumor-prom…”
BackgroundBreaking the aging epigenetic barrier
Sikder, S., Arunkumar, G., Melters, D. P., & Dalal, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.943519 · Cited by 12
“Apart from causing major chronic inflammation, SASP also act via autocrine and paracrine pathways (Acosta et al., 2008; Acosta et al., 2013).”
BackgroundCellular senescence and abdominal aortic aneurysm: From pathogenesis to therapeutics
Wang, D., Hao, X., Jia, L., Jing, Y., Jiang, B., & Xin, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.999465 · Cited by 19
“IL-1α, TGF-β and IL-6 promote senescence in a cellular autonomous manner, while many other SASP factors act in a non-cellular autonomous manner, thus altering the behavior of neighboring cells (48, 49).”
BackgroundDNA damage, inflammation and aging: Insights from mice
Arvanitaki, E. S., Stratigi, K., & Garinis, G. A. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.973781 · Cited by 17
“Senescent cells with chromatin hallmarks of irreparable DSBs secrete a wide range of senescence-associated secretory phenotype (SASP) factors, including inflammatory cytokines and chemokines as well as growth factors and extracellular matrix remodeling enzymes (Coppe et al., 2008; Ohanna et al., 2011; Acosta et al., 2…”
BackgroundNavitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice
Watanabe, Y., Abé, H., Kimura, N., Arao, Y., Ishikawa, N., Yuichiro, M., Setsu, T., Sakamaki, A., Kamimura, H., Yokoo, T., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13879 · Cited by 14
“Senescent cells are known to have bystander effects (negative effects) through paracrine on surrounding non‐senescent cells.(23,35,36) Therefore, even though the changes in the number of”
BackgroundSenotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly
Li, Z., Tian, M., Wang, G., Cui, X., Ma, J., Liu, S., Shen, B., Liu, F., Wu, K., Xiao, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1098712 · Cited by 15
Hom, L. M., Sun, S., Campbell, J., Liu, P., Culbert, S., Murphy, I. M., & Schafer, Z. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104922 · Cited by 11
“In addition, the composition of the SASP includes several factors that are linked to inflammatory caspase activation through regulation of (or by) inflammasome complexes (53, 54).”
BackgroundSenescence-Derived Extracellular Molecules as Modulators of Oral Cancer Development: A Mini-Review
Parkinson, E. K., James, E. L., & Prime, S. S. (2015) · Gerontology · doi:10.1159/000440954 · Cited by 16
Matić, I., Revandkar, A., Chen, J., Bisio, A., Dall’Acqua, S., Cocetta, V., Brun, P., Mancino, G., Milanese, M., Mattei, M., et al. (2016) · Aging · doi:10.18632/aging.101076 · Cited by 13
“www.aging‐us.com 3226 AGING (Albany NY) SH extract is a potent suppressor of PICS and replicative senescence in human primary dermal fibroblasts.”
BackgroundInfluentialElucidating Proteoform Dynamics Underlying the Senescence Associated Secretory Phenotype
Doubleday, P. F., Fornelli, L., & Kelleher, N. L. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00739 · Cited by 14
Tiwari, D. K., Hannen, R., Unger, K., Kohl, S., Heß, J., Lauber, K., Subtil, F. S. B., Dikomey, E., Engenhart‐Cabillic, R., & Schötz, U. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.878675 · Cited by 14
“Especially the roles of the IL1 pathway are manifold with pivotal contributions to senescence, stress response, and inflammation (20, 21).”
BackgroundPertussis: an update on primary prevention and outbreak control.
Scott, P. T., Clark, J. B., & Miser, W. F. (1997) · PubMed · Cited by 12
Multi-omics and single cell characterization of cancer immunosenescence landscape
Wei, Q., Chen, R., He, X., Qu, Y., Yan, C., Liu, X., Liu, J., Luo, J., Yu, Z., Hu, W., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03562-z · Cited by 14
“The previous studies have shown that the immune reaction of CS is activated by a positive feed-back regulation of the SASP factors such IL1, IL6, IL8, IFN-I, TGF and TNF 33,45,47–53 .”
Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases
Jaganathan, R., Iyaswamy, A., Krishnamoorthi, S., Thakur, A., Durairajan, S. S. K., Yang, C., & Wankhar, D. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1627921 · Cited by 9
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
“These effects are mediated by SASP components such as EREG, PDGF-AA, HGF and several MMPs, and by signaling pathways including TGF-β and Notch, which coordinate communication among the fibroblast, immune, and epithelial compartments 23,72,73,209 .”
Senescent cells in tissue engineering
Chin, A. F., & Elisseeff, J. H. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102737 · Cited by 13
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
Romaniello, D., Gelfo, V., Pagano, F., Sgarzi, M., Morselli, A., Girone, C., Filippini, D. M., D’Uva, G., & Lauriola, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1083743 · Cited by 15
“A mechanism already reported as SASP mediated paracrine senescence, which can impact on tumour suppression and senescence in vivo (Acosta et al., 2013).”
BackgroundSkeletal Senescence with Aging and Type 2 Diabetes
Farr, J. N. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1727 · Cited by 14
“and matrix degrading/remodeling proteins [17-19].”
Aging and oral squamous cell carcinoma development: the role of cellular senescence
Niklander, S. E., Aránguiz, P., Faunes, F., & Flores, R. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1285276 · Cited by 20
Liu, D., Hsueh, S., Tweedie, D., Price, N., Glotfelty, E. J., Lecca, D., Telljohann, R. S., de Cabo, R., Hoffer, B. J., & Greig, N. H. (2024) · Brain Communications · doi:10.1093/braincomms/fcae204 · Cited by 14
“44 SASP microglia thus have the potential to promote an inflammatory microenvironment and propagate senescence to neighbouring cells via paracrine senescence; 45 thus ex-acerbating local cells including cholinergic system degeneration at BF of AD.”
BackgroundGenetic and Epigenetic Interactions Involved in Senescence of Stem Cells
Iordache, F., Ionescu, A., & Alexandru, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179708 · Cited by 14
“These mechanisms determine the accumulation of senescent cells both in tumor and normal tissue [5–11].”
BackgroundSasia, C., Borgonetti, V., Mancini, C., Lori, G., Arbiser, J. L., Taddei, M. L., & Galeotti, N. (2024) · Cells · doi:10.3390/cells13191652 · Cited by 17
“SASP acts in a paracrine fashion to induce secondary senescence in surrounding cells [57], a process that involves Notch1 signaling [35].”
BackgroundA biosensory μvessel-gravity device for advancing vascular analysis in space medicine
Xu, K., Wang, X., Bai, H., Wu, G., Zhang, W., Zhou, J., Zhang, P., Zhang, X., Peng, B., Voelcker, N. H., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116923 · Cited by 13
Tomkova, K., Roman, M., Adebayo, A. S., Sheikh, S., Yusoff, S., Gulston, M. K., Joel‐David, L., Lai, F. Y., Murgia, A., Eagle‐Hemming, B., et al. (2024) · npj Aging · doi:10.1038/s41514-024-00183-z · Cited by 12
Specific types of male infertility are correlated with T cell exhaustion or senescence signatures
Amodio, G., Giacomini, G., Boeri, L., Raffo, M., Cilio, S., Pozzi, E., Belladelli, F., Negri, F., Ferrara, A. M., d’Arma, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56193-2 · Cited by 17
Intracellular signaling modules linking DNA damage to secretome changes in senescent melanoma cells
Chavanet, A., Hill, K. R., Jiménez-Andrade, Y., Choo, M., White, K., & Park, J. M. (2020) · Melanoma Research · doi:10.1097/cmr.0000000000000671 · Cited by 12
Long-Term Treatment of Azathioprine in Rats Induces Vessel Mineralization
Schuchardt, M., Herrmann, J., Henkel, C., Babic, M., van der Giet, M., & Tölle, M. (2021) · Biomedicines · doi:10.3390/biomedicines9030327 · Cited by 13
“The activation of those SASP cytokines is in line with further research that found an induction of “paracrine senescence” in cell culture as well as mouse models [38].”
ResultGremlin 2 suppresses differentiation of stem/progenitor cells in the human skin
Kawagishi‐Hotta, M., Hasegawa, S., Inoue, Y., Hasebe, Y., Arima, M., Iwata, Y., Sugiura, K., & Akamatsu, H. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.06.007 · Cited by 12
Small, S. H., Tang, E. J., Ragland, R. L., Ruzankina, Y., Schoppy, D. W., Mandal, R. S., Glineburg, M. R., Ustelenca, Z., Powell, D. J., Simpkins, F. A., et al. (2021) · Science Signaling · doi:10.1126/scisignal.aba2611 · Cited by 14
“To examine the effect of inhibiting inflammasome-mediated processing on IL19 expression, cells were treated with a selective inhibitor of caspase-1, an inflammasome component that is required for efficient IL-1 processing and production (10, 11), immediately after IR treatment.”
BackgroundHe, Y., Lipa, K. E., Alexander, P. G., Clark, K. L., & Lin, H. (2022) · Biology · doi:10.3390/biology11070996 · Cited by 16
Hodge, J., Robinson, J. L., & Mellott, A. J. (2022) · Regenerative Medicine · doi:10.2217/rme-2022-0140 · Cited by 11
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.